What is transverse myelitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Transverse Myelitis?

Transverse myelitis is an acute inflammatory disease of the spinal cord characterized by rapid onset of bilateral motor weakness, sensory disturbances, and autonomic dysfunction (bladder, bowel, and sexual impairment) that typically progresses to maximal severity within 10 days of symptom onset. 1, 2

Pathophysiology

  • The condition involves focal inflammation of the spinal cord with perivascular monocytic and lymphocytic infiltration, demyelination, and axonal injury 3
  • The inflammatory process primarily damages the spinal cord gray matter, causing upper motor neuron dysfunction above the lesion level 1
  • This upper motor neuron involvement results in spastic paralysis with hyperreflexia (increased deep tendon reflexes), which is a key distinguishing feature from lower motor neuron disorders like Guillain-Barré syndrome 1

Clinical Presentation

  • At maximal clinical severity, approximately 50% of patients develop complete paraparesis, nearly all have sensory disturbances, and 80-94% experience numbness, paresthesias, or band-like dysesthesias 2, 3
  • Bladder dysfunction occurs in virtually all patients, with urinary retention and constipation being common autonomic manifestations 1, 3
  • Symptoms evolve rapidly over hours to days, with most patients reaching peak severity within 10 days 2
  • The bilateral nature of symptoms with a sensory level below the lesion is characteristic 4

Etiologic Categories

The causes are diverse and can be classified into several broad categories 4:

  • Demyelinating conditions (multiple sclerosis, neuromyelitis optica spectrum disorder) 5
  • Autoimmune disorders (systemic lupus erythematosus, Sjögren's syndrome, sarcoidosis) - particularly associated with antiphospholipid antibodies 5, 6
  • Parainfectious causes (HIV, HTLV-1, viral infections) 5, 4
  • Paraneoplastic syndromes 5
  • Drug/toxin-induced 4
  • Idiopathic - despite extensive workup, many cases remain without identified cause 2

Diagnostic Features on MRI

  • MRI shows T2-weighted hyperintense lesions in the spinal cord that appear wedge-shaped on axial views and cigar-shaped on sagittal views 1
  • Longitudinally extensive transverse myelitis (affecting ≥3 contiguous vertebral segments) should raise suspicion for neuromyelitis optica spectrum disorder 1, 5
  • Multiple sclerosis typically presents with shorter lesions (<3 vertebral segments) 5

Prognosis

  • Residual disability is divided approximately equally into three groups: severe disability, moderate disability, and minimal or no disability 2, 3
  • Poor prognostic factors include extensive spinal cord lesions (≥3 vertebral segments), reduced muscle strength or sphincter dysfunction at presentation, and delayed treatment initiation (>2 weeks) 7
  • Relapses occur in 50-60% of cases during corticosteroid dose reduction 7

Key Clinical Pitfall

The presence of increased deep tendon reflexes (spastic paralysis) is the critical distinguishing feature of transverse myelitis compared to conditions causing flaccid paralysis with reduced reflexes, such as Guillain-Barré syndrome or poliomyelitis 1

References

Guideline

Transverse Myelitis Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

MRI in transverse myelitis.

Journal of magnetic resonance imaging : JMRI, 2014

Research

Demyelinating disorders: update on transverse myelitis.

Current neurology and neuroscience reports, 2006

Research

Transverse myelitis.

Neurologic clinics, 2013

Guideline

Differential Diagnosis for Acute Transverse Myelitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Transverse Myelitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.